Michael Seckler
Director Ejecutivo en EVOME MEDICAL TECHNOLOGIES INC. .
Fortuna: - $ al 31/05/2024
Perfil
Michael D.
Seckler is currently the Chief Executive Officer & Director at Evome Medical Technologies, Inc., as well as a Director at GLyPharma Therapeutic, Inc. and K2 Biotechnology Ventures LLC.
Previously, he held the position of Vice President-Global Marketing at Ferring Pharmaceuticals, Inc. from 2017 to 2019.
He also served as the Chief Operating Officer at FerGene, Inc. from 2022 to 2023.
Mr. Seckler obtained his undergraduate degree and MBA from The Pennsylvania State University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 14/06/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Cargos activos de Michael Seckler
| Empresas | Cargo | Inicio |
|---|---|---|
| EVOME MEDICAL TECHNOLOGIES INC. | Director Ejecutivo | 13/06/2023 |
GLyPharma Therapeutic, Inc.
 GLyPharma Therapeutic, Inc. BiotechnologyHealth Technology GLyPharma Therapeutic, Inc. develops oncology therapeutic treatment. It engages in the development of the clinical efficacy of FE 203799, a novel proprietary Glucagon-Like Peptide-2(GLP-2) analogue exerting unique pharmacological effects in a first-in-class, meaningful indication for patients with hematological malignancies receiving myelotoxic therapies. The company was founded in August 2012 and is headquartered in Montreal, Canada. | Director/Miembro de la Junta | - |
K2 Biotechnology Ventures LLC
 K2 Biotechnology Ventures LLC Miscellaneous Commercial ServicesCommercial Services K2 Biotechnology Ventures LLC engages in accelerating the commercialization of university, medical center, and healthcare innovations. The private company is based in Chicago, IL. The company was founded by Kenneth B. Kashkin, Jane E. Kiernan. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Michael Seckler.
| Empresas | Cargo | Fin |
|---|---|---|
FerGene, Inc.
 FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Director de Operaciones | 01/05/2023 |
Ferring Pharmaceuticals, Inc.
 Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Ventas & Marketing | 01/12/2019 |
Formación de Michael Seckler.
| The Pennsylvania State University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| EVOME MEDICAL TECHNOLOGIES INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Health Technology |
GLyPharma Therapeutic, Inc.
GLyPharma Therapeutic, Inc. BiotechnologyHealth Technology GLyPharma Therapeutic, Inc. develops oncology therapeutic treatment. It engages in the development of the clinical efficacy of FE 203799, a novel proprietary Glucagon-Like Peptide-2(GLP-2) analogue exerting unique pharmacological effects in a first-in-class, meaningful indication for patients with hematological malignancies receiving myelotoxic therapies. The company was founded in August 2012 and is headquartered in Montreal, Canada. | Health Technology |
FerGene, Inc.
FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Health Technology |
K2 Biotechnology Ventures LLC
K2 Biotechnology Ventures LLC Miscellaneous Commercial ServicesCommercial Services K2 Biotechnology Ventures LLC engages in accelerating the commercialization of university, medical center, and healthcare innovations. The private company is based in Chicago, IL. The company was founded by Kenneth B. Kashkin, Jane E. Kiernan. | Commercial Services |
- Bolsa de valores
- Insiders
- Michael Seckler
